NYC MAYOR BILL DE BLASIO TO JOIN THE NATION’S MAYORS IN MIAMI BEACH
Jun 23, 2017 13:04 pm UTC| Business
Washington, D.C, June 23, 2017 -- New York City Mayor Bill de Blasio will address the nation’s mayors this week during the U.S. Conference of Mayors 85th Annual Meeting, which runs from Friday, June 23 to Monday, June...
Flexion Therapeutics Named One of Boston Business Journal’s Best Places to Work
Jun 23, 2017 13:00 pm UTC| Business
BURLINGTON, Mass., June 23, 2017 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been recognized as one of the The Boston Business Journal’s “Best Places to Work.” Flexion ranked 5th in the...
Jun 23, 2017 13:00 pm UTC| Business
FORT WORTH, Texas, June 23, 2017 -- The American Airlines Education Foundation yesterday awarded $801,000 in scholarships to 300 children of employees, an increase of 5 percent compared to 2016. ...
AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment
Jun 23, 2017 13:00 pm UTC| Business
NEW YORK, June 23, 2017 -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark...
Younan Properties Sells Black Canyon Corporate Center
Jun 23, 2017 13:00 pm UTC| Business
Los Angeles, June 23, 2017 -- Younan Properties Inc., (YPI) an international commercial real estate owner and manager, has completed the sale of Black Canyon Corporate Center in Phoenix to Tower Investments, LLC,...
Hunt Mortgage Group Refinances a Multifamily Property in Charleston, South Carolina
Jun 23, 2017 13:00 pm UTC| Business
NEW YORK, June 23, 2017 -- Hunt Mortgage Group, a leader in financing commercial real estate throughout the United States, announced today it provided a Fannie Mae loan in the amount of $12.4 million to refinance a...
CohBar, Inc. Announces Private Placement Offering
Jun 23, 2017 13:00 pm UTC| Business
MENLO PARK, Calif., June 23, 2017 -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat...